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Here, we present a comprehensive in vitro char-
acterization of the excised iterative, bimodular
PCP-TE of the gramicidin S synthetase GrsB,
which is able to act both as a ligation and a cycli-
zation catalyst. Using the native pentapeptidyl-
thioester substrates, GrsB PCP-TE catalyzes
the dimerization and subsequent formation of
the decapeptide lactam gramicidin S. Interest-
ingly, the detection of linear decapeptidyl-
SNAC as an enzyme-dependent intermediate
supports the iterative mechanism in vivo, in
which two pentapeptides, one bound as an es-
ter to the active site serine of the TE domain and
the second bound as a thioester to the adjacent
pan-PCP, are ligated to a decapeptidyl-pan-
PCP that subsequently transferred to the adja-
cent TE domain and cyclized. Moreover, GrsB
PCP-TE can handle different substrates length,
leading not only to dimerization, but also to tri-
merization and the formation of different ring
sizes.
INTRODUCTION
Many bioactive peptides of diverse structures are pro-
duced via a template-directed manner by multimodular
enzymes called nonribosomal peptide synthetases
(NRPSs) [1]. A common feature of such nonribosomally
synthesized bioactive peptides is their macrocyclic struc-
ture, which causes reduction in structural flexibility and
may therefore constrain them into the biologically active
conformation [2]. Macrocyclic products are released
from NRPS assembly lines usually by the action of C-
terminal thioesterase domains (TE domains, cyclases).
These accomplish product release by diverse mecha-
nisms, mainly including a head-to-tail or branched side
chain cyclization resulting in the formation of the final
cyclic product [3, 4]. Excised TE domains, separated
from their biosynthetic machinery, are active enzymes in
vitro when provided with substrate mimics. Due to the
fact that stereoselective peptide cyclization is a difficult
task in organic synthesis, chemoenzymatic methods
have emerged for the production of natural products and
their derivatives [5]. These approaches combine substrateChemistry & Biology 14, 1generation by solid-phase peptide synthesis and stereo-
selective cyclization utilizing excised TE domains.
Based on the mechanism of peptide assembly and
product release, NRPSs can be subdivided into three dif-
ferent classes [6]. Best characterized are the linear NRPSs
(Type A), which are exemplified by the tyrocidine and the
surfactin synthetases [1]. In these systems, the sequence
of the assembled peptide chain is entirely determined by
the number and order of modules within the correspond-
ing peptide synthetase. Several TE domains of linear
NRPSs are biochemically and structurally well character-
ized and are frequently used in chemoenzymatic ap-
proaches to generate macrocyclic peptide derivatives
[7–13]. In contrast, iterative (Type B) and nonlinear (Type C)
NRPS assembly line templates are more complex. For
example, iterative synthetases use their modules and
domains more than once to assemble their final products
from repetitive building blocks. Prominent candidates for
the iterative mechanism are the antibiotic gramicidin S,
the siderophore enterobactin, the antitumor agent thio-
coraline, and the potent anti-SARS-CoV valinomycin, as
well as the anticancer drug bleomycin and the siderophore
yersiniabactin for nonlinear NRPS-PKS hybrids [14–19].
To clarify the mechanistic aspects and to explore the
biocombinatorial potential of the iterative reaction, we
investigated the TE domain of the gramicidin S synthetase
for its substrate specificity, ligation capacity, and cycliza-
tion potential.
Gramicidin S is a potent and well-characterized antibi-
otic synthesized by Bacillus brevis [14]. It is a cyclic
decapeptide with the primary structure cyclo(-D-Phe1-
L-Pro2- L-Val3- L-Orn4- L-Leu5 -D-Phe6- L-Pro7- L-Val8-
L-Orn9- L-Leu10-), which is assembled on the GrsA and
GrsB peptide synthetases that comprise one and four
modules, respectively (Figure 1). The modular organiza-
tion of the peptide synthetases suggests a mechanism
in which the gramicidin TE (GrsB TE) serves as a holding
bay for the gramicidin linear pentapeptide intermediate.
After formation of the first pentapeptide, the TE domain
awaits the assembly of the second pentapeptide and
catalyzes the dimerization and the release of the cyclic
decapeptide lactam. This type of mechanism was first
proposed by Stoll et al. back in 1970 and was previously
supported by mass spectrometric studies on the TE
domain of the iterative enterobactin (Ent) synthetase
[15, 20]. Early studies also discussed enzyme dimerization,
and they determined that the utilization of two TE domains
to catalyze this two-step mechanism would lead to the3–22, January 2007 ª2007 Elsevier Ltd All rights reserved 13
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Iterative Gramicidin ThioesteraseFigure 1. The Gramicidin S Biosynthetic
Machinery
The enzymatic assembly line consists of two
NRPSs (GrsA and GrsB), which are composed
of one and four modules, respectively. Each
module is responsible for the incorporation
of one monomeric amino acid. The thioester-
ase domain (TE domain) catalyzes the dimer-
ization of two assembled pentapeptides and
subsequent cyclization, resulting in gramicidin
S. A, adenylation; PCP, peptidyl carrier pro-
tein; E, epimerization; C, condensation; TE,
thioesterase.same product. However, this seems rather unlikely, as it
has been shown for GrsA and the iterative enterobactin
synthetase EntF, harboring the TE domain, that NRPSs
work as monomers [21].
Here, we report in vitro studies on the characterization
of an iterative TE domain. We demonstrate that the
excised GrsB TE can act in vitro both as a ligation and
a cyclization catalyst. Results obtained with peptidyl
thioester substrates of different lengths enable a new bio-
combinatorial approach and a suggestion for a reaction
mechanism.
RESULTS
Definition of the GrsB TE N-Terminal Border
In order to explore the potential of the excised GrsB TE
domain to catalyze the cyclization of artificial, linear gram-
icidin thioester substrates, we generated a recombinant
protein comprising the TE domain together with its adja-
cent peptidyl-carrier protein (GrsB PCP-TE, 59 kDa, 365
residues) [22]. Heterologous expression in Escherichia
coli BL21 cells at 25C resulted in the production of the
recombinant apo protein in sufficient yields (4 mg/l,
Figure S1; see the Supplemental Data available with this
article online).
In order to exclude the possibility that the PCP domain
is indispensable for the iterative reaction of the PCP-TE
construct, we additionally investigated the activity of the
single TE domain. To define the borders of the TE domain,14 Chemistry & Biology 14, 13–22, January 2007 ª2007 Elseviewe performed sequence alignments, which revealed that
the published borders of gramicidin thioesterase [7] com-
prise about 25 amino acid residues as an N-terminal
extension compared to most characterized linear TE
domains [7–13]. Sequence alignments of GrsB TE with
the iterative TE domains of EntF, DhbF, and TioS revealed
that this N-terminal extension seems to be a unique fea-
ture of GrsB TE (Figure 2). Based on these sequence align-
ments, it was possible to define two putative N-terminal
borders of the GrsB TE domain. Based on this finding,
a long version (TELong, 33 kDa, 275 residues) and a short
version (TEShort, 30 kDa, 250 residues) were cloned and
expressed in the soluble and active forms (Figure S1).
Comparison of the reaction time courses of GrsB PCP-
TE and GrsB TELong incubated with the pentapeptidyl-
thioester and the decapeptidyl-thioester revealed similar
rates of product formation. In contrast, GrsB TEShort cata-
lyzes a 5-fold slower product formation. Due to good sol-
ubility and the best yields of the GrsB PCP-TE, all further
experiments were conducted with this construct.
Characterization of GrsBPCP-TEActivity with Native
Linear Substrates
Based on previous results [7, 23], in which the decap-
eptidyl-SNAC (GS10) was used as the substrate, we
synthesizedGS10 (Table 1) for initial activity studies. Incu-
bation of the excised GrsB PCP-TE with GS10 resulted in
the formation of the expected cyclic decapeptide gramici-
din S (tR = 43.0, Figure 3A). The kinetic parameters for ther Ltd All rights reserved
Chemistry & Biology
Iterative Gramicidin ThioesteraseFigure 2. Sequence Alignment of the Linker Region between PCP and Thioesterase of Different NRPSs
The vertical bars mark the start of the short and long versions of the GrsB thioesterase (GrsB TELong, GrsB TEShort). Conserved residues are marked
in dark gray. The putative linker region of all synthetases is marked in bright gray. grsB, gramicidin S synthetase B; dhbF, bacillibactin synthetase F;
entF, enterobactin synthetase F; tioS, thiocoraline synthetase S; fenB, fengycin synthetase B; tycC, tyrocidine synthetase C; snbDE, pristinamycin
synthetase DE; srfC, surfactin synthetase C.cyclization reaction revealed a catalytic efficiency of kcat/
KM = 5.5 min
1 mM1 (KM = 0.24 mM, kcat = 1.3 min
1).
A common mechanistic feature in iterative NRPS sys-
tems is the ability to combine two or more identical mono-
mers. Therefore, the major question for excised GrsB
PCP-TE was whether the recombinant protein is able to
catalyze an iterative reaction in vitro. For this purpose,
we synthesized the native pentapeptidyl-SNAC and
-thiophenol substrates, GS5SNAC, GS5SPh (Table 1), re-
spectively, and incubated them with the GrsB PCP-TE.
In both cases, the HPLC trace revealed that GrsB PCP-
TE catalyzes the dimerization of the pentapeptides to
a decapeptide and its subsequent cyclization, resulting
in the formation of gramicidin S (tR = 43.1) (Figures 3B
and 3C). The formation of gramicidin S in this reaction
occurred with a kcat value of 0.4 min
1 for GS5SNAC and
a kcat value of 2.4 min
1 for GS5SPh. Taking into account
that the linear gramicidin substrate possesses two nucle-
ophiles, L-Orn4 and the N terminus of D-Phe1, MS-MS
sequencing of the cyclic decapeptide was conducted.
The results obtained excluded the possibility that L-Orn4
is involved in ring formation. Cyclization is exclusively me-
diated through a nucleophilic attack of the a amino group
of D-Phe1; fragment ions proving the predicted linkage of
D-Phe1 to L-Leu5 were unambiguously identified (Fig-
ure S2). In addition to the main product, gramicidin S,
and hydrolysis of the pentamer, linear decapeptidyl-
SNAC (5+5) and a 15-membered ring (5+5+5) (at low con-
centrations) consisting of three pentapeptide monomers
were detected as side products (ratio hydrolysis/gramici-
din S: 1/4). In the case of GS5SPh, such a linear decepep-
tidyl intermediate was not observed (ratio hydrolysis/
gramicidin S: 1/3). Interestingly, GS5SPh forms a 5-mem-
bered ring in an enzyme-independent reaction, which is
not observed with the SNAC-activated substrate. Com-
parison of the assay conducted with and without enzyme
showed that the enzyme-catalyzed reaction is faster than
the uncatalyzed formation of the 5-membered ring. For
stability reasons, we used peptidyl-SNACs instead of
thiophenols for all further studies.Chemistry & Biology 14,Substrate Specificity of GrsB PCP-TE
Encouraged by the obtained results, we wanted to gain in-
sight into the substrate tolerance of the thioesterase. For
this purpose, single amino acid residues in the native pen-
tapeptide substrate were exchanged stepwise for alanine
and were screened for the formation of the corresponding
decapeptides. Substrates substituted in positions 2
(L-Pro2), 3 (L-Val3), and 4 (L-Orn4) revealed the formation
of a 10-membered ring with the corresponding linear
SNAC intermediate and small amounts of the 15-mem-
bered ring, indicating the tolerance of GrsB PCP-TE for
those positions within the pentapeptide (Tables 1 and 2,
the ratio of hydrolysis/linear and cyclic products is:
GS5SNAC, 1/4; GS5Ala2, 1/2.5; GS5Ala3, 6/1; GS5Ala4,
1/1.5). The velocity of the reaction was about the same
for the tested substrates (conversion of substrate after
10 min: GS5SNAC, 11%; GS5Ala2, 6%; GS5Ala3, 9%;
GS5Ala4, 9%). Interestingly, in the assays with the alanine
pentapeptide derivatives, the ratio of the 15-membered
ring to the 10-membered ring is different (ratio 10-
membered ring/15-membered ring:GS5SNAC, 6/1;GS5Ala2,
5/1; GS5Ala3, 2/1; GS5Ala4, n.d.). To corroborate these
results, we determined the kinetic parameters for the
cyclization reaction of the corresponding SNAC decapep-
tidesGS10Ala2,7,GS10Ala3,8, andGS10Ala4,9 (Tables 1 and 2;
GS10Ala2,7: KM, 357 mM, kcat, 4 min
1; GS10Ala3,8: KM,
485 mM, kcat, 3.4 min
1). Unfortunatley, we had solubility
problems withGS10Ala4,9; thus, we were not able to deter-
mine kinetic parameters. Additionally, we altered the
configuration of the amino acids at positions 1 and 5.
Substrates carrying D-Leu at the C terminus (GS5D-Leu5
and GS10D-Leu10) showed low hydrolysis rates, whereas
substrates carrying L-Phe at the N terminus (GS5L-Phe1
and GS10L-Phe1) were mainly hydrolyzed. Cyclization and
dimerization were not observed.
Variations of Substrate Length
Focusing on the impact of different substrate lengths for
the oligomerization and cyclization reaction, we created
a library based on the structure of gramicidin S that13–22, January 2007 ª2007 Elsevier Ltd All rights reserved 15
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Iterative Gramicidin ThioesteraseTable 1. ESI-Mass Spectrometric Characterization of Synthesized Linear Substrates
Compound Sequence
Species
(m/z)
Observed Mass
(Calculated Mass)
GS2 D-Phe1- L-Leu2- SNAC [M + H]
+ 380.2 (380.2)
GS3 D-Phe1- L-Pro2- L-Leu3- SNAC [M + H]
+ 477.2 (477.3)
GS4 D-Phe1- L-Pro2- L-Orn3- L-Leu4- SNAC [M + H]
+ 591.2 (591.3)
GS5SNAC D-Phe1- L-Pro2- L-Val3- L-Orn4- L-Leu5- SNAC [M + H]
+ 690.5 (690.4)
GS5SPh D-Phe1- L-Pro2- L-Val3- L-Orn4- L-Leu5- SPh [M + H]
+ 681.5 (681.4)
GS5Ala2 D-Phe1- L-Ala2- L-Val3- L-Orn4- L-Leu5- SNAC [M + H]
+ 664.5 (664.4)
GS5Ala3 D-Phe1 -L-Pro2 -L-Ala3 -L-Orn4 -L-Leu5 -SNAC [M + H]
+ 662.5 (662.4)
GS5Ala4 D-Phe1- L-Pro2- L-Val3- L-Ala4- L-Leu5- SNAC [M + H]
+ 647.4 (647.4)
GS5L-Phe1 D-Phe1- L-Pro2- L-Val3- L-Orn4- L-Leu5- SNAC [M + H]
+ 690.5 (690.4)
GS5D-Leu5 D-Phe1- L-Pro2- L-Val3- L-Orn4- D-Leu5- SNAC [M + H]
+ 690.5 (690.4)
GS5NAc NAc-D-Phe1- L-Pro2- L-Val3- L-Orn4- L-Leu5- SNAC [M + H]
+ 732.4 (732.4)
GS5OH D-Phe1- L-Pro2- L-Val3- L-Orn4- L-Leu5 [M + H]
+ 589.4 (589.4)
GS6 D-Phe1- L-Pro2- L-Val3- L-Val4- L-Orn5- L-Leu6- SNAC [M + H]
+ 789.5 (789.5)
GS7 D-Phe1- L-Pro2- L-Val3- L-Pro4- L-Val5- L-Orn6- L-Leu7- SNAC [M + H]
+ 886.5 (886.5)
GS8 D-Phe1- L-Pro2- L-Val3- L-Orn4- L-Pro5- L-Val6- L-Orn7-
L-Leu8- SNAC
[M + H]+ 1000.6 (1000.6)
GS9 D-Phe1- L-Pro2- L-Val3- L-Orn4- L-Leu5- L-Pro6- L-Val7-
L-Orn8- L-Leu9- SNAC
[M + H]+ 1113.8 (1113.7)
GS10 D-Phe1- L-Pro2- L-Val3- L-Orn4- L-Leu5- D-Phe6- L-Pro7-
L-Val8- L-Orn9- L-Leu10- SNAC
[M + H]+ 1260.7 (1260.7)
GS10L-Phe1 L-Phe1- L-Pro2- L-Val3- L-Orn4- L-Leu5- D-Phe6- L-Pro7-
L-Val8- L-Orn9- L-Leu10- SNAC
[M + H]+ 1260.7 (1260.7)
GS10D-Leu10 D-Phe1- L-Pro2- L-Val3- L-Orn4- L-Leu5- D-Phe6- L-Pro7-
L-Val8- L-Orn9- D-Leu10- SNAC
[M + H]+ 1260.7 (1260.7)
GS10Ala2,7 D-Phe1- L-Ala2- L-Val3- L-Orn4- L-Leu5- D-Phe6- L-Ala7-
L-Val8- L-Orn9- L-Leu10- SNAC
[M + H]+ 1208.7 (1208.7)
GS10Ala3,8 D-Phe1- L-Pro2- L-Ala3- L-Orn4- L-Leu5- D-Phe6- L-Pro7-
L-Ala8- L-Orn9- L-Leu10- SNAC
[M + H]+ 1204.7 (1204.7)
GS10Ala4,9 D-Phe1- L-Pro2- L-Val3- L-Ala4- L-Leu5- D-Phe6- L-Pro7-
L-Val8- L-Ala9- L-Leu10- SNAC
[M + H]+ 1174.7 (1174.7)contained peptides that varied in length. These substrates
were synthesized by excluding stepwise internal amino
acids of the linear gramicidin S decapeptide. Starting by
assaying the smallest dipeptide,GS2 (Table 1), only hydro-
lysis could be detected. In addition, the slow formation of
diketopiperazin as a prominent nonenzymatic reaction
was visible. These results indicate that the dipeptide GS2
seems to be too short for the conversion catalyzed by
the thioesterase. By using additional substrates of varying
lengths it was possible to detect, in addition to hydrolysis,
the formation of different ring sizes. The tripeptide GS3
(Tables 1 and 2) was dimerized by the thioesterase and
was subsequently cyclized into a 6-membered ring (3+3)
as the single product. Consecutively, we incubated a tetra-
peptide, GS4 (Table 1), with GrsB PCP-TE. After 90 min of
incubation, one-third of this tetrapeptide was converted16 Chemistry & Biology 14, 13–22, January 2007 ª2007 Elsevieinto two products, an 8-membered (48%, 4+4) and a 12-
membered (21%, 4+4+4) ring (Table 2). Side product forma-
tion could be assigned to the hydrolyzed monomer (10%),
the hydrolyzed octapeptide (4+4, 5%), and the activated
octapeptidyl-SNAC (4+4, 16%).
With further increases of the peptide length, the ability of
GrsB PCP-TE to dimerize or even trimerize the incubated
substrate is reduced. Assaying the reaction of a hexapep-
tide, GS6 (Table 1), exclusively led to a 6-membered ring.
The heptapeptideGS7 (Tables 1 and 2) was dimerized and
was subsequently cyclized into a 14-membered ring (7+7).
The octapeptide GS8 (Tables 1 and 2) was converted into
an 8-membered ring and a linear dimer (8+8) of the
substrate. For the nonapeptide GS9 (Tables 1 and 2),
cyclization was exclusively observed, as described for
the decapeptide GS10.r Ltd All rights reserved
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Iterative Gramicidin ThioesteraseThese results indicate that GrsB PCP-TE catalyzes the
ring formation of 6- to 15-membered rings achieved by li-
gation and cyclization reactions.
Construction of a Cyclic Peptide Library
In order to get an impression of the ligation and cyclization
potential of GrsB PCP-TE, we performed assays in which
substrates differing in composition and length were com-
bined and screened for the assembly of novel products.
Mixing the tetrapeptide GS4 and the pentapeptide
GS5SNAC in the presence of GrsB PCP-TE led to an
8-membered (4+4), a 10-membered (5+5), and a 12-mem-
bered (4+4+4) ring (Figure 4). In addition, formation of
a novel 13-membered ring (4+4+5) consisting of two tetra-
and one pentapeptide monomer could be detected.
Figure 3. Dimerization and Cyclization of Pentapeptidyl- and
Decapeptidyl-Thioesters Mediated by the GrsB PCP-TE
(A) Incubation of GS10 (300 mM) with PCP-TE (10 mM) for 60 min.
(B) Incubation of GS5SNAC (300 mM) with PCP-TE (10 mM) for 60 min.
(C) Incubation of GS5SPh (300 mM) with PCP-TE (10 mM) for 60 min.
The blue HPLC trace corresponds to the assay with enzyme, and the
red trace shows incubation of the substrate in the absence of the en-
zyme. Analysis was performed on a C18 Nucleodur column (Macherey
and Nagel; 250/2; pore diameter, 100 A˚; particle size, 3 mM) with the
following gradient: 0–40 min, 5%–60% MeCN/0.1% TFA into H2O/
0.1% TFA, 40–45 min, 60%–95% MeCN/0.1% TFA into H2O/0.1%
TFA, 0.3 ml/min, 45C.Chemistry & Biology 14These results were exploited in two additional experi-
ments, in which the substrates GS3 and GS4 were com-
bined and led to the formation of an 8-membered (4+4),
a 12-membered (4+4+4), and an 11-membered (4+4+3)
ring (Table 2). Likewise, the incubation of GrsB PCP-TE
with the two substrates, GS4 and GS6, resulted in the for-
mation of an additional 10-membered ring (6+4) (Table 2).
Probing the Ligase Activity of GrsB PCP-TE
Generally, NRPS condensation (C) domains catalyze the
peptide bond ligation of activated amino acids along the
nascent peptide chain [24]. As iterative TE domains medi-
ate the linkage of smaller monomers before cyclization,
the question of whether the excised GrsB PCP-TE can
potentially act as a ligase arises. To test this ability, we
had to impede the GrsB PCP-TE from acting as a cyclase.
This was achieved by blocking either the N or C terminus
of the suitable linear monomers. In a first set of experi-
ments, we incubated GrsB PCP-TE with a pentapeptide,
GS5OH, that was not activated as a thioester. As ex-
pected, no conversion was detectable. Additionally, an
activated pentapeptidyl-SNAC, GS5NAc, that was N-
terminally acylated, was constructed. Assaying this sub-
strate with GrsB PCP-TE resulted exclusively in hydroly-
sis, whereas coincubation of both substrates, GS5OH
and GS5NAc, led to the ligation of these pentapeptides,
which, in turn, resulted in a linear decapeptide (ratio
ligation/hydrolysis: 1/2, using 300 mM of each substrate).
This reaction clearly indicated the ability of GrsB PCP-
TE to catalyze a ligation reaction. Following Michaelis-
Menten kinetics, this ligation reaction was determined to
a kcat of 4.9 min
1 and a KM of 0.62 mM for GS5OH and
a kcat of 7.3 min
1 and a KM of 1.1 mM for GS5NAc.
DISCUSSION
Recent studies on several TE domains dissected from
various NRPS systems opened new approaches for the
in vitro generation of macrocyclic bioactive compounds
and allowed the characterization of their dedicated regio-
and stereoselective cyclization mechanisms. With the
biochemical characterization of the iterative TE domain
of gramicidin S we present here a class of TE domains
with high potential for biocombinatorial synthesis. In con-
trast to linear TE domains, iterative GrsB TE not only cat-
alyzes the regio- and stereoselective cyclization of linear
peptide precursors, but additionally catalyzes peptide
bond ligation.
The GrsB PCP-TE was tested by using the native linear
decapeptide GS10 and pentapeptides GS5SNAC and
GS5SPh, which leads to the formation of the desired cyclic
decapeptide lactam gramicidin S (Figure 3). This clearly
indicated that the excised TE domain catalyzes both elon-
gation and cyclization in vitro. Former studies with the
same pentapeptidyl-SNAC indicated a barely detectable
dimerization activity catalyzed by GrsB TE [7]. In contrast,
our results prove not only dimerization, but also subse-
quent cyclization, resulting in gramicidin S in sufficient
yields for thiophenol- and SNAC-activated substrates., 13–22, January 2007 ª2007 Elsevier Ltd All rights reserved 17
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Iterative Gramicidin ThioesteraseTable 2. ESI-Mass Spectrometric Characterization of Cyclic Products
Ring Size Substrate Cyclic Species
Species
(m/z)
Observed Mass
(Calculated Mass)
6-membered GS6 Cyclo(-D-Phe1- L-Pro2- L-Val3- L-Val4- L-Orn5- L-Leu6-) [M + H]
+ 670.5 (670.4)
6-membered GS3 Cyclo(-D-Phe1- L-Pro2- L-Leu3-)2 [M + H]
+ 715.5 (715.4)
8-membered GS4 Cyclo(-D-Phe1- L-Pro2- L-Orn3- L-Leu4-)2 [M + H]
+ 943.5 (943.6)
8-membered GS8 Cyclo(-D-Phe1- L-Pro2- L-Val3- L-Orn4- L-Pro5- L-Val6-
L-Orn7- L-Leu8-)
[M + H]+ 881.5 (881.6)
9-membered GS9 Cyclo(-D-Phe1- L-Pro2- L-Val3- L-Orn4- L-Leu5- L-Pro6-
L-Val7- L-Orn8- L-Leu9-)
[M + H]+ 994.5 (994.6)
10-membered GS5SNAC,
GS5SPh or GS10
Cyclo(-D-Phe1- L-Pro2- L-Val3- L-Orn4- L-Leu5-)2 [M + H]
+ 1141.7 (1141.7)
10-membered GS5Ala2 Cyclo(-D-Phe1- L-Ala2- L-Val3- L-Orn4- L-Leu5-)2 [M + H]
+ 1089.8 (1089.7)
10-membered GS5Ala3 Cyclo(-D-Phe1 -L-Pro2 -L-Ala3 -L-Orn4 -L-Leu -)2 [M + H]
+ 1085.5 (1085.6)
10-membered GS5Ala4 Cyclo(-D-Phe1- L-Pro2- L-Val3- L-Ala4- L-Leu5-)2 [M + H]
+ 1055.6 (1055.6)
10-membered GS10Ala2,7 Cyclo(-D-Phe1- L-Ala2- L-Val3- L-Orn4- L-Leu5-)2 [M + H]
+ 1089.7 (1089.7)
10-membered GS10Ala2,8 Cyclo(-D-Phe1 -L-Pro2 -L-Ala3 -L-Orn4 -L-Leu -)2 [M + H]
+ 1085.7 (1085.6)
10-membered GS10Ala2,9 Cyclo(-D-Phe1- L-Pro2- L-Val3- L-Ala4- L-Leu5-)2 [M + H]
+ 1055.7 (1055.6)
10-membered GS6 and GS4 Cyclo(-D-Phe1- L-Pro2- L-Val3- L-Val4- L-Orn5-
L-Leu6-D-Phe7- L-Pro8- L-Orn9- L-Leu10-)
[M + H]+ 1141.7 (1141.7)
11-membered GS4 and GS3 Cyclo(-D-Phe1- L-Pro2- L-Orn3- L-Leu4- D-Phe5-
L-Pro6-L-Orn7- L-Leu8- D-Phe9- L-Pro10- L-Leu11-)
[M + H]+ 1300.7 (1300.8)
12-membered GS4 Cyclo(-D-Phe1- L-Pro2- L-Orn3- L-Leu4-)3 [M + H]
+ 1414.8 (1414.9)
13-membered GS4 and
GS5SNAC
Cyclo(-D-Phe1- L-Pro2- L-Orn3- L-Leu4- D-Phe5-
L-Pro6-L-Orn7- L-Leu8- D-Phe9- L-Pro10- L-Val11-
L-Orn12- L-Leu13-)
[M + H]+ 1513.8 (1513.9)
14-membered GS7 Cyclo(-D-Phe1- L-Pro2- L-Val3- L-Pro4- L-Val5- L-Orn6-
L-Leu7-)2
[M + H]+ 1533.8 (1533.9)
15-membered GS5SNAC Cyclo(-D-Phe1- L-Pro2- L-Val3- L-Orn4- L-Leu5-)3 [M + H]
+ 1712 (1712.1)
15-membered GS5Ala2,7 Cyclo(-D-Phe1- L-Ala2- L-Val3- L-Orn4- L-Leu5-)3 [M + H]
+ 1633.9 (1634)
15-membered GS5Ala3,8 Cyclo(-D-Phe1- L-Pro2- L-Ala3- L-Orn4- L-Leu5-)3 [M + H]
+ 1627.9 (1628)
15-membered GS5Ala4,9 Cyclo(-D-Phe1- L-Pro2- L-Val3- L-Ala4- L-Leu5-)3 [M + H]
+ 1582.9 (1582.9)Dimerization activity by TE domains of linear NRPSs has
been described only once thus far [13]. Here, the gramici-
din S pentapeptidyl-SNAC was used in combination with
the excised tyrocidine TE, leading to hydrolysis as the ma-
jor product and small amounts of dimerized and cyclized
products. In comparison, dimerization and cyclization
catalyzed by GrsB PCP-TE is indeed slower, but they
are only accompanied by low rates of hydrolysis (ratio
cycle(5+5)/hydrolysis 4/1 for GS5SNAC). Kinetic investiga-
tions show that the conversion of the pentapeptide into
gramicidin S is slower than the conversion of the decap-
eptide, possibly due to the fact that the ligation reaction
of the pentapeptide is the rate-determining step. Using
the pentapeptidyl-SNAC as the substrate, a decapep-
tidyl-SNAC was generated in an enzyme-dependent reac-
tion. The detection of this decapeptidyl-SNAC gave rise
to speculations about the mechanism of iterative TE
domains. The SNAC intermediate can be formed by the18 Chemistry & Biology 14, 13–22, January 2007 ª2007 Elsevinucleophilic attack of the amino group of a free SNAC
pentapeptide on the peptidylester of the TE-bound penta-
peptide. If the free amino group of the TE-bound substrate
would attack the thioester of the SNAC-activated peptide,
only hydrolyzed linear substrates could be detected as
side products. These observations can also aid in the
understanding of the reaction catalyzed by iterative thio-
esterases in vivo. For the enterobactin synthetase,
Shaw-Reid et al. [15] postulated that the first monomer
is built up by the synthetase and is subsequently trans-
ferred to the active site serine of the TE domain. The sec-
ond monomer is presented by the pan-arm of the PCP
domain adjacent to Ent-TE. The ligation reaction results
in a dimer bound as an ester to the active site serine of
the TE domain. Two possible mechanisms for this elonga-
tion reaction can be postulated (Figure 5). Either the amino
group of the first monomer bound to the TE domain nucle-
ophilicaly attacks the second monomer presented by theer Ltd All rights reserved
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ine of the TE domain (forward reaction), or the amino
group of the PCP-bound substrate attacks the TE-bound
monomer, resulting in a dimer bound to the PCP domain,
that is subsequently transferred to the active site serine of
the TE domain for cyclization (backward reaction). Ac-
cording to our results, there is strong evidence that the
GrsB TE utilizes the backward reaction, as we were able
to detect the formation of the decapeptidyl-SNAC. To
date, it cannot be verified whether the decapeptidyl-
SNAC is a side product or an intermediate of the reaction.
In the forward reaction, a second catalytic center would be
required to catalyze the ligation reaction because the
serine of the catalytic triad is blocked by the first mono-
mer. Comprehensive sequence alignments of several TE
domains revealed that the gramicidin TE domain has an
extension of about 25 amino acids (Figure 2). Expression
of this longer version of the GrsB TE domain (GrsB TELong)
Figure 4. Coincubation of GS4 and GS5SNAC with GrsB PCP-
TE, Resulting in the Formation of aMixture of Cyclic Products
Blue trace: incubation of GS4 (D-Phe- L-Pro- L-Orn- L-Leu-SNAC, 300
mM) and GS5SNAC (D-Phe- L-Pro- L-Val- L-Orn- L-Leu-SNAC, 300 mM)
with GrsB PCP-TE (10 mM) for 1 hr at 25C. Red trace: control reaction
without enzyme. Due to high retention time differences between sub-
strates GS4 and GS5SNAC and products, only product composition is
shown. a, (4+4)-SNAC; b, (5+5); c, cyclo(4+4); d, cyclo(4+4+4); e,
cyclo(5+4+4); f, cyclo(5+5).Chemistry & Biology 14,published by Kohli et al. [7], and a short version (GrsB
TEShort) missing the 25 amino acids resulted in compara-
ble dimerization and cyclization activity. Although the
obtained products were found in equal parts, the catalytic
efficiency of GrsB TEShort is 5-fold lower, indicating an im-
portant role of the N-terminal extension for protein stabil-
ity. Also, the iterative gramicidin TE domain has a longer
linker region between the PCP and the TE domain that
was not observed in other PCP-TE junctions. This ex-
tended linker region may be important for flexibility of
the thioesterase needed to catalyze two different reac-
tions: the ligation of two substrates and intramolecular
cyclization. Structural analysis of this iterative TE might
provide insights into these mechanistic issues.
To investigate the cyclization and ligation ability of GrsB
PCP-TE for biocombinatorial approaches, we determined
its substrate tolerance. The alanine screen of the linear
pentapeptide clearly indicates that residues at positions
2–4 in the substrate are tolerant of substitutions, which
is shown by the time course of the reaction and the given
product ratios (ratio of hydrolysis/linear and cyclic prod-
ucts: GS5SNAC, 1/4; GS5Ala2, 1/2.5; GS5Ala3, 6/1; GS5Ala4,
1/1.5, and conversion of substrate after 10 min: GS5SNAC,
11%; GS5Ala2, 6%; GS5Ala3, 9%; GS5Ala4, 9%). To cor-
roborate these results, we synthesized the corresponding
decapeptides and were able to show, for two of these
substrates, that the cyclization reaction is characterized
by higher KM and kcat values (GS10: KM, 241 mM, kcat,
1.3 min1; GS10Ala2,7: KM, 357 mM, kcat, 4 min
1;
GS10Ala3,8: KM, 485 mM, kcat, 3.4 min
1). However, posi-
tions 1 and 5, which are directly involved in the elonga-
tion and/or cyclization reaction, are not accessible to
alteration of the stereogenic configuration. The tolerance
for substitutions of L-Val3, L-Orn4, and D-Phe6 of the de-
capeptide in the cyclization reaction mediated by GrsB
TE was shown by Guo [23]. Similar substrate toleranceFigure 5. Postulated Mechanisms of the Dimerization Reaction Catalyzed by GrsB PCP-TE
In the forward reaction (indicated by black arrows), the pentapeptide attached to the TE nucleophilically attacks the thioester of pentapeptidyl-pan-
PCP, resulting in the formation of a linear decapeptide directly bound to the active site serine of the TE domain. In the backward reaction (indicated by
red arrows), the amino group of pentapeptidyl-pan-PCP attacks the ester of the pentapeptide attached to the thioesterase. This leads to the deca-
peptide bound to the PCP domain, which is subsequently transferred to the TE domain for cyclization.13–22, January 2007 ª2007 Elsevier Ltd All rights reserved 19
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domains [7–13].
How iterative thioesterases can control the number of
ligation steps of the repetative basic units remains un-
known. The results obtained from assays with substrates
of different lengths and substrate mixtures revealed that
whether an elongation or a cyclization reaction occurs is
determined by two different aspects: the preorganization
of the substrate and the size of the obtained ring. This
mechanism was suggested recently based on the com-
parison of the two known crystal structures of TE domains
of linear NRPSs [12].
Previously, Wadhwani and Bu investigated the pre-fold
of the linear native gramicidin S decapeptide substrate
[25, 26]. They were able to show that even the linear
substrate adopts a similar b sheet structure to gramicidin S
itself. Encouraged by these results, we propose that
the pre-fold of the substrate might be important for the
efficiency of the catalytic reaction. The impact of the
substrate pre-fold was also shown for the thioesterase
excised from the tyrocydine synthetase, whose cycliza-
tion potential depends on the pre-fold of the linear sub-
strate that is used [27]. Taking into consideration the
2(2n+1) rule [28] and the reported structures of various
ring sizes of gramicidin S [29], we propose that some linear
substrates possess a higher b sheet content than others.
The smallest ring formed by the GrsB PCP-TE contains
six residues and a stabilized b sheet structure, obtained by
the cyclization of the hexapeptide GS6 and by the dimer-
ization prior to cyclization of the smallest accepted tripep-
tide, GS3. The heptapeptide GS7 is elongated once, and
subsequent cyclization led to a 14-membered ring. The
14-membered ring likewise has a stabilized b sheet
structure that is preferred to an unstabilized 7-membered
ring. This indicates that the elongation and subsequent
cyclization to an energetically favored ring size is preferred
by GrsB PCP-TE. Larger peptides containing more than
seven amino acids were exclusively cyclized. Although
the larger 18-membered ring is believed to have a b sheet
structure, this cyclization was not observed when the TE
domain was incubated with the nonapeptide GS9;
instead, a 9-membered ring was exclusively formed.
This can be explained by the maximum capacity of the
catalytic pocket of the thioesterase. GrsB PCP-TE can
sufficiently cyclize linear peptides consisting of 6–15
amino acids, reflecting the high variability, flexibility, and
limitation of the binding pocket. For the tetrapeptide
GS4, an 8-membered (4+4) and 12-membered (4+4+4)
ring were observed. These products are not in accordance
with the b sheet rule. It becomes clear that b sheet
structures are impossible to assemble by monomers of
this size. In these cases, size exclusion mediated by the
thioesterase led to the formation of the dedicated ring
sizes.
Reactions including different sizes of peptide sub-
strates revealed that not only dimerization, but also ring
compositions of both incubated substrates, of the dedi-
cated monomers could be detected. These findings
open the gate for generating peptide libraries derived20 Chemistry & Biology 14, 13–22, January 2007 ª2007 Elsevifrom mixtures of small peptides that are randomly as-
sembled to cyclic compounds.
Interestingly, the GrsB PCP-TE can also function as a
ligase. This can be achieved by blocking the cyclization
reaction with suitable substrate monomers, whose cycli-
zation nucleophile is blocked. Such ligation products are
detected by a coincubation of two substrates, one of
which is not activated at the C terminus, whereas the other
is blocked at the N terminus. Results obtained so far indi-
cated a high degree of substrate tolerance. Therefore, it
remains an interesting task to determine the maximum
length that can be utilized for this ligation reaction.
In summary, we show that the excised thioesterase of
gramicidin S has relaxed substrate specificity and is able
to convert substrates of different lengths into the dedi-
cated cycles. Because GrsB TE can catalyze two different
reactions, cyclization and ligation, it is possible to obtain
cyclic peptide libraries built by ligation and cyclization of
linear peptides differing in length and amino acid compo-
sition. We believe that GrsB TE, or iterative operating TE
domains in general, will become a powerful tool for
biocombinatorial engineering of novel cyclic and linear
peptidic compounds.
SIGNIFICANCE
Many bioactive compounds, like valinomycin, thio-
coraline, and enterobactin, are synthesized on itera-
tive types of NRPSs. In contrast to linear NRPS
systems, iterative synthetases use their modules
more than once. In these systems, thioesterases
were suggested to catalyze a ligation of repetitive
peptidyl intermediates prior to a cyclization reaction.
Here, we present a comprehensive in vitro character-
ization of the excised iterative, bimodular PCP-TE of
the gramicidin S synthetase GrsB. We show that the
TE domain catalyzes the ligation and subsequent
cyclization of peptidyl-SNAC and -thiophenols. Detec-
tion of linear thioester intermediates supports amech-
anism in vivo, in which the ligation product of the two
pentapeptides is transferred backward to the PCP
domain to be cyclized by the TE domain afterwards
(backward reaction). Using different substrates, we
were able to define the substrate specificity of this
particular iterative thioesterase. Most importantly,
GrsB PCP-TE is able to handle peptides of different
lengths, leading to direct cyclization or dimerization
or even trimerization reactions and the formation of
various ring sizes. Encouraged by these observations,
we were able to show that this class of thioesterases
can be applied to the generation of libraries of cyclic
compounds by randomly triggered assembly ofmono-
mers out of a pool of small peptides. Additionally,
GrsB PCP-TE can be used as a ligation catalyst. To-
gether, our investigations characterize this iterative
thioesterase as a useful tool for biocombinatorial
approaches that may lead to the synthesis of new bio-
active products.er Ltd All rights reserved
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Strains, Culture, Media, and General Methods
Escherichia coli strains were grown in LB medium supplemented, if ap-
plicable, to the final concentration of 100 mg/ml ampicillin, 25–50 mg/ml
kanamycin. Oligonucleotides were purchased from Qiagen Operon.
Standard protocols were applied for all DNA manipulations [30]. Amino
acids were purchased from Novabiochem, Bachem Biosciences, and
IRIS biotech. All other compounds, except HBTU and HOBt$H2O (IRIS
Biotech), were purchased from Sigma-Aldrich.
Construction of Expression Plasmids
Gene fragments encoding for GrsB PCP-TE (12,262–13,356 bp) and
TE (GrsB TEShort, 12,608–13,351 bp; GrsB TELong, 12,527–13,351 bp)
were amplified by PCR from chromosomal DNA of Bacillus brevis
ATCC 9999 by using Pfu Turbo DNA polymerase (Stratagene) with
the following oligonucleotides: GrsB PCP-TE, 50- CACCGAGTATG
TTGCACCAAGGAA-30 and 50-TTTTACTACAAATGTCCCTTGTAG-30;
GrsB TELong, 5
0-TTTCCATGGTAAACGAAGCAGATAG-30 and 50-ATT
GGATCCTACAAATGTCCCTTGTAG-30; GrsB TEShort, 50-TTTCCATGG
TAAACGAAGAAACAGATCG-30 and 50- ATTGGATCCTACAAATGT
CCCTTGTAG-30. The PCR product of GrsB PCP-TE was inserted into
the pBAD202/D-TOPO vector (Invitrogen). The PCR product of GrsB
TELong was cloned into the NcoI/BamHI site of pQE60 (Qiagen), and the
PCR product of GrsB TEShort was inserted into the NcoI and BamHI
sites of pCL11, a pET16b derivative (Novagen) containing the
BamHI/HindIII fragment of pQE60 encoding a hexahistidine tag [31].
All inserted fragments were confirmed by sequencing (GATC Biotech).
Expression and Purification of Recombinant Enzymes
E. coli BL21 (Amersham Biosciences) or M15/pREP4 (Qiagen) was
transformed with the desired plasmids. Cells were grown to OD 0.6
(600 nm), induced with 0.01% arabinose or 0.1 mM IPTG, and culti-
vated for an additional 2.5 hr at 25C/30C. The expressed proteins
were purified by Ni-NTA affinity chromatography (GE Healthcare).
Fractions containing the recombinant proteins, identified by SDS-
PAGE (12.5%, Supplemental Data), were pooled and dialyzed against
assay buffer (25 mM HEPES, 50 mM NaCl [pH 7.5]).
The concentration of the purified proteins was determined spectro-
photometrically by using the estimated extinction coefficient at
280 nm. After being flash frozen in liquid nitrogen, the proteins were
stored at 80C.
Synthesis of Linear Thioester Substrates
Peptide synthesis was carried out on an Advanced ChemTech APEX
396 synthesizer (0.1 mmol scale) with 2-chlorotrityl resin (IRIS Biotech)
as described previously [32]. Preparation and purification of N-
acetylcysteamine- and thiophenol-thioester peptides were performed
as described earlier [32]. The identity of the thioester substrates was
determined by reverse-phase liquid chromatography-mass spectrom-
etry (RP-LCMS, Agilent 1100 MSD) (Table 1). Peptides were solubilized
in standard assay buffer to a final concentration of 15 mM and variable
amounts of DMSO (<20% v/v).
Enzyme Assays
Standard reactions were conducted in a total volume of 50 ml, at 25C,
in assay buffer (25 mM HEPES, 50 mM NaCl [pH 7.5]) containing a sub-
strate concentration of 300 mM. Reactions were initiated by the addi-
tion of 10 mM enzyme and were quenched after 90 min by the addition
of 10 ml 4% TFA/H2O. In order to verify the role of the thioesterase in
these reactions, a control without enzyme in which the formation of
products was completely abolished was always performed. Assays
were analyzed by RP-LCMS (Agilent 1100 MSD) on a Nucleodur
125/3 C18 (ec) column (Macherey and Nagel; pore diameter, 100 A˚;
particle size, 3 mm) utilizing the following gradient: 0–40 min, 5%–
60% MeCN/0.1% TFA into H2O/0.1% TFA, 40–45 min, 60%–95%
MeCN/0.1% TFA into H2O/0.1% TFA, 0.5 ml/min, 40
C; the identities
of the products were verified by ESI-MS.Chemistry & Biology 14,Kinetic characterizations of the dimerization and cyclization reac-
tions were performed by determining initial rates at 5–8 substrate con-
centrations by using 2 time points at each concentration within the
linear region of the reaction. Kinetic parameters of the ligation reaction
were determined by using one substrate in excess and by varying the
other substrate concentration. The concentrations of all thioester sub-
strates were calculated by using experimentally determined extinction
coefficients at a wavelength of 215 nm. Concentrations of products
were calculated by comparison with synthesized linear peptides with
identical sequences. Assays were analyzed by RP-LCMS (Agilent
1100 MSD) on a Nucleodur 125/2 C18 (ec) column (Macherey and
Nagel; pore diameter, 100 A˚; particle size, 3 mm) with the following
gradients: native penta- and decapeptide substrates activated as
thioester: 0–35 min, 5%–90% MeCN/0.1% TFA into H2O/0.1% TFA,
0.4 ml/min, 45C; ligation of GS5OH and GS5SNAC: 0–45 min, 5%–
90% MeOH/0.1% TFA into H2O/0.1% TFA, 0.4 ml/min, 45
C.
Supplemental Data
Supplemental Data include SDS-PAGE of GrsB PCP-TE, GrsB TELong,
and GrsB TEShort and MS-MS sequencing of the product derived from
GS5SNAC and are available at http://www.chembiol.com/cgi/content/
full/14/1/13/DC1/.
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